According to Vericel 's latest financial reports the company's current earnings (TTM) are -$1.77 M. an increase over its 2022 earnings that were of -$15.63 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$1.77 M | -88.68% |
2022 | -$15.63 M | 106.12% |
2021 | -$7.58 M | -348.49% |
2020 | $3.05 M | -131.58% |
2019 | -$9.66 M | 50.77% |
2018 | -$6.41 M | -60.41% |
2017 | -$16.18 M | -15.96% |
2016 | -$19.26 M | 17.89% |
2015 | -$16.34 M | -17.99% |
2014 | -$19.92 M | 27.56% |
2013 | -$15.62 M | |
2011 | -$29.04 M | |
2009 | -$16.4 M | -11.13% |
2008 | -$18.46 M | -12.47% |
2007 | -$21.09 M | 11.4% |
2006 | -$18.93 M | 23.76% |
2005 | -$15.3 M | 44.39% |
2004 | -$10.59 M | 3.56% |
2003 | -$10.23 M | 14.22% |
2002 | -$8.96 M | 11.76% |
2001 | -$8.02 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | $1.88 B | -106,846.61% | ๐ฌ๐ง UK |
Neogen NEOG | -$0.26 M | -85.52% | ๐บ๐ธ USA |